Frontlight ResearchEarly access
Trial site
Labderm Essence Sp. z o.o.
- 8running trials
- 6closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Hidradenitis suppurativa9 trials
- Alopecia areata2 trials
- Chronic spontaneous urticaria2 trials
- Atopic dermatitis (eczema)1 trial
- Lupus (SLE)1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 38 trials
- Phase 25 trials
- Phase 11 trial
- Status
- Completed6 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Lead sponsor
- MoonLake Immunotherapeutics AG2 trials
- Pfizer2 trials
- ACELYRIN Inc.1 trial
- Almirall, S.A.1 trial
- AstraZeneca AB1 trial
- and 7 more
Running trials
Not yet recruiting
Recruiting
A Proof-of-Concept Study of LAD328 in Adults With Hidradenitis Suppurativa
Recruiting
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Terminated
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hidradenitis suppurativa2 recruiting
- Alopecia areata1 recruiting
- Atopic dermatitis (eczema)1 recruiting
- Lupus (SLE)1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Terminated
Completed
Site data: EU CTIS (euclinicaltrials.eu)Updated 15 Nov 2026